Burke Steven Keith

Avg. Two Year Performance

(15%) Avg. Purchase Return
(7%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return65%130%201%(15%)(15%)
Purchase Success Rate2 of 22 of 22 of 20 of 20 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Akebia Therapeutics, Inc.

Drugs » Biotechnology

SVP, Chief Medical Officer:

Holdings: 695.84K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Protara Therapeutics, Inc.

Drugs » Biotechnology

SVP and Chief Medical Officer:

Holdings: 147.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--